Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
PRCH
|
Matt Ehrlichman
CEO, CHAIRMAN AND FOUNDER |
SELL
Payment of exercise price or tax liability
|
Direct | 18,393 Reduced 0.2% |
$107,047
$5.82 p/Share
|
Apr 08
2022 |
PRCH
|
Matt Ehrlichman
CEO, CHAIRMAN AND FOUNDER |
BUY
Grant, award, or other acquisition
|
Direct | 46,743 Added 0.5% |
-
|
Apr 08
2022 |
PRCH
|
Matthew Neagle
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,123 Reduced 1.53% |
$41,456
$5.82 p/Share
|
Apr 08
2022 |
PRCH
|
Matthew Neagle
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 24,647 Added 5.04% |
-
|
Apr 08
2022 |
DLTH
|
David Homolka
SVP,Talent,Oper.,AP&Safety |
SELL
Payment of exercise price or tax liability
|
Direct | 679 Reduced 1.0% |
$8,365
$12.32 p/Share
|
Apr 08
2022 |
DLTH
|
David Loretta
SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,289 Reduced 1.54% |
$15,880
$12.32 p/Share
|
Apr 08
2022 |
DLTH
|
Richard W Schlecht
SVP, Product Dev. & Sourcing |
SELL
Payment of exercise price or tax liability
|
Direct | 453 Reduced 0.5% |
$5,581
$12.32 p/Share
|
Apr 08
2022 |
DLTH
|
Christopher Teufel
SVP IT and Logistics |
SELL
Payment of exercise price or tax liability
|
Direct | 453 Reduced 0.82% |
$5,581
$12.32 p/Share
|
Apr 08
2022 |
CIFR
|
Top Hold Co B.V. Bitfury
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 2,890,173 Reduced 1.4% |
$9,999,999
$3.46 p/Share
|
Apr 08
2022 |
MDXG
|
Robert Benjamin Stein
President, Regenerative Med. |
BUY
Grant, award, or other acquisition
|
Direct | 178,571 Added 33.87% |
$824,998
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
Peter M Carlson
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 187,500 Added 24.75% |
$866,250
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
Rohit Kashyap
President, WC & Surgical |
BUY
Grant, award, or other acquisition
|
Direct | 178,571 Added 28.76% |
$824,998
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
William Lawrence Phelan
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 53,030 Added 26.07% |
$244,999
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
Scott M Turner
SVP, Operations & Procurement |
BUY
Grant, award, or other acquisition
|
Direct | 61,472 Added 20.95% |
$284,001
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
Mark Graves
SVP & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct | 48,485 Added 26.07% |
$224,001
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
William Frank Iv Hulse
General Counsel and CAO |
BUY
Grant, award, or other acquisition
|
Direct | 178,571 Added 32.86% |
$824,998
$4.62 p/Share
|
Apr 08
2022 |
MDXG
|
Timothy R Wright
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 602,679 Added 24.84% |
$2,784,377
$4.62 p/Share
|
Apr 08
2022 |
HIPO
|
Fifth Wall Ventures Management Gp, LLC
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect | 3,345,998 Added 11.56% |
-
|
Apr 08
2022 |
HIPO
|
Fifth Wall Ventures Management Gp, LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 25,701,973 Reduced 49.76% |
-
|
Apr 08
2022 |
ATAI
|
Apeiron Investment Group Ltd. |
BUY
Open market or private purchase
|
Indirect | 57,689 Added 4.43% |
$277,484
$4.81 p/Share
|
Apr 08
2022 |
ACRE
|
Anton Feingold
Gen. Counsel VP and Secretary |
SELL
Open market or private sale
|
Direct | 935 Reduced 2.43% |
$14,558
$15.57 p/Share
|
Apr 08
2022 |
LPG
|
Theodore B. Young
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 10.16% |
$192,125
$15.37 p/Share
|
Apr 08
2022 |
LPG
|
Thomas Jason Coleman
Director |
SELL
Open market or private sale
|
Indirect | 100,000 Reduced 3.11% |
$1,540,000
$15.4 p/Share
|
Apr 08
2022 |
MVIS
|
Sumit Sharma
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 300,000 Added 26.35% |
-
|
Apr 08
2022 |
OSW
|
Andrew R Heyer |
SELL
Open market or private sale
|
Indirect | 1,005 Reduced 0.19% |
$10,563
$10.51 p/Share
|
Apr 08
2022 |
OSW
|
Andrew R Heyer |
SELL
Open market or private sale
|
Direct | 903 Reduced 0.16% |
$9,491
$10.51 p/Share
|
Apr 08
2022 |
SUMO
|
Ramin Sayar
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 337,533 Added 26.64% |
-
|
Apr 08
2022 |
SUMO
|
Christian Beedgen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 72,007 Added 3.08% |
-
|
Apr 08
2022 |
SUMO
|
Katherine Haar
General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 36,003 Added 13.82% |
-
|
Apr 08
2022 |
LAW
|
Andrew Shimek
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 10.6% |
$473,550
$31.57 p/Share
|
Apr 08
2022 |
CMP
|
James D. Standen
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,048 Reduced 4.24% |
$64,389
$61.44 p/Share
|
Apr 08
2022 |
CMP
|
James D. Standen
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,567 Added 12.62% |
-
|
Apr 08
2022 |
CMP
|
Kevin S Crutchfield
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,834 Reduced 17.2% |
$481,321
$61.44 p/Share
|
Apr 08
2022 |
CMP
|
Kevin S Crutchfield
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,954 Added 31.51% |
-
|
Apr 08
2022 |
CMP
|
Teresa D Cook
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 129 Reduced 6.51% |
$7,926
$61.44 p/Share
|
Apr 08
2022 |
CMP
|
Teresa D Cook
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 433 Added 17.93% |
-
|
Apr 08
2022 |
RPAY
|
Tyler B Dempsey
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 804 Reduced 0.4% |
$12,108
$15.06 p/Share
|
Apr 08
2022 |
RXRX
|
Christopher Gibson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 36,920 Reduced 9.79% |
$243,303
$6.59 p/Share
|
Apr 08
2022 |
RXRX
|
Christopher Gibson
Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect | 2,500 Added 50.0% |
-
|
Apr 08
2022 |
RXRX
|
Christopher Gibson
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 44,010 Added 10.93% |
$109,145
$2.48 p/Share
|
Apr 08
2022 |
RXRX
|
Christopher Gibson
Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct | 18,500 Added 4.91% |
-
|
Apr 08
2022 |
RXRX
|
Christopher Gibson
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 100.0% |
$16,750
$6.7 p/Share
|
Apr 08
2022 |
OXM
|
Thomas Caldecot Chubb Iii
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 7,000 Reduced 10.66% |
$636,790
$90.97 p/Share
|
Apr 08
2022 |
AIR
|
Christopher A. Jessup
Senior Vice President-CCO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,200 Added 6.85% |
$76,800
$24.0 p/Share
|
Apr 08
2022 |
AIR
|
Christopher A. Jessup
Senior Vice President-CCO |
SELL
Open market or private sale
|
Direct | 6,100 Reduced 13.15% |
$302,621
$49.61 p/Share
|
Apr 08
2022 |
WGO
|
Donald Jeff Clark
PRESIDENT - GRAND DESIGN |
BUY
Grant, award, or other acquisition
|
Indirect | 58,525 Added 7.41% |
$3,160,350
$54.0 p/Share
|
Apr 08
2022 |
EBS
|
Coleen Glessner
EVP, Quality & Ethics, and CPL |
BUY
Grant, award, or other acquisition
|
Direct | 11,826 Added 50.0% |
-
|
Apr 08
2022 |
ATRC
|
Tonya Austin
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 282 Reduced 1.34% |
$17,368
$61.59 p/Share
|
Apr 08
2022 |
COUR
|
Shravan Goli
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 27.81% |
$2,136,000
$21.36 p/Share
|
Apr 08
2022 |
COUR
|
Shravan Goli
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 100,000 Added 21.76% |
$223,000
$2.23 p/Share
|
Apr 08
2022 |